-transparent.png){kind=logo}
A sustained-release preparation of procainamide (PAD) was evaluated in a double-blind cross-over study. The preparation was found to reduce ventricular ectopic activity in all seven patients who completed the investigation in five patients the effectiveness reached the defined level of significance. A larger clinical trial to assess the long-term use of this preparation in terms of efficacy, safety and convenience is recommended.
Related Publications
G E Bauer, and
A S Mitchell, and
F Bates, and
K Hellestrand
January 1982,
The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,
G E Bauer, and
A S Mitchell, and
F Bates, and
K Hellestrand
March 1974,
Acta medica Scandinavica,
G E Bauer, and
A S Mitchell, and
F Bates, and
K Hellestrand
June 1984,
Drug intelligence & clinical pharmacy,
G E Bauer, and
A S Mitchell, and
F Bates, and
K Hellestrand
April 1985,
Archives of internal medicine,
G E Bauer, and
A S Mitchell, and
F Bates, and
K Hellestrand
September 1984,
Annals of internal medicine,
G E Bauer, and
A S Mitchell, and
F Bates, and
K Hellestrand
February 1984,
Annals of internal medicine,
G E Bauer, and
A S Mitchell, and
F Bates, and
K Hellestrand
October 1988,
The American journal of cardiology,
G E Bauer, and
A S Mitchell, and
F Bates, and
K Hellestrand
January 1976,
British heart journal,
G E Bauer, and
A S Mitchell, and
F Bates, and
K Hellestrand
November 1984,
Canadian Medical Association journal,
G E Bauer, and
A S Mitchell, and
F Bates, and
K Hellestrand
February 1982,
Angiology,
